Preparations of phospholipids and pharmaceuticals containing...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/24 (2006.01) A61K 9/127 (2006.01) A61K 9/16 (2006.01) A61K 9/50 (2006.01) A61K 31/606 (2006.01) A61K 47/44 (2006.01)

Patent

CA 2657769

A unique composition of a 5-amino salicylic acid (5 AS A) and a phospholipid is disclosed for treating Inflammatory Bowel Disease (IBD), where the composition can be a mixture, a molecular association complex or a covalent compound of 5ASA and a reactive phospholipid covalently bonded together via a diazo linkage and to methods for administering the compositions to treat symptoms of IBD.

L'invention concerne une composition unique constituée d'un acide salicylique 5-aminé (5 ASA) et d'un phospholipide. Cette composition est destinée à traiter une maladie intestinale inflammatoire (MII). Cette composition peut être un mélange, un complexe d'associations moléculaires ou un composé covalent de 5 ASA et d'un phospholipide réactif reliés de manière covalente par une liaison diazo. L'invention concerne également des procédés d'administration de telles compositions destinés à traiter des symptômes de MII.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Preparations of phospholipids and pharmaceuticals containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preparations of phospholipids and pharmaceuticals containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparations of phospholipids and pharmaceuticals containing... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1415228

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.